top of page

Publications

Original Article

Soluble cytokines can act as effective adjuvants in plasmid DNA vaccines targeting self tumor antigens

Cancer Vaccines

2003

Authors:

Disis ML, Shiota FM, McNeel DG, Knutson KL

Journal:

immunobiology

Volume:

207(3)

Page:

179-86

Review Article

TOWARD A BREAST CANCER VACCINE: WORK IN PROGRESS-REVIEW

Cancer Vaccines

2003

Authors:

Knutson KL and Disis ML

Journal:

Oncology

Volume:

17(9)

Page:

1217-8

Review Article

Clinical studies of vaccines targeting breast cancer

Clinical Trials

2003

Authors:

Ko BK, Kawano K, Murray JL, Disis ML, Efferson CL, Kuerer HM, Peoples GE, Ioannides CG

Journal:

Clinical Cancer Research

Volume:

9(9)

Page:

3222-34

Review Article

Immunotherapy for breast cancer

2002

Authors:

Knutson KL, Bishop MR, Schiffman K, and Disis ML

Journal:

Cancer Chemotherapy and Biological Response Modifiers Annual

Volume:

20

Page:

351-69

Review Article

Immunologic targets for breast cancer

Cancer Vaccines

2002

Authors:

Disis ML

Journal:

Breast Disease

Volume:

15

Page:

83-90

Review Article

Immunologic monitoring of cancer vaccine therapy: results of a workshop sponsored by the Society for Biological Therapy

Measuring Human Immunity

2002

Authors:

Kielholz U, Weber J, Finke J, Gabrilovich D, Kast M, Disis ML, Kirkwood J, Scheibenbogen C, Scholm J, Maino V, Lyerly HK, See P, Storkus W, Marincola F, Worobec A, Atkins MB

Journal:

Journal of Immunotherapy

Volume:

25(2)

Page:

97-138

Review Article

Cancer vaccines targeting the HER2/neu oncogenic protein

Cancer Vaccines

2002

Authors:

Disis ML

Journal:

Biological Therapy of Breast Cancer

Volume:

4(3)

Page:

11-4

Original Article

Delayed type hypersensitivity response to recall antigens does not accurately reflect immune competence in advanced stage breast cancer patients

General Immune Research

2002

Authors:

Schiffman K, Rinn K, Disis ML

Journal:

Breast Cancer Research and Treatment

Volume:

74(1)

Page:

17-23

Original Article

Flt3 ligand as a vaccine adjuvant in association with HER-2/neu peptide-based vaccines in patients with HER-2/neu-overexpressing cancers

Cancer Vaccines

2002

Authors:

Disis ML, Rinn K, Knutson KL, Davis D, Caron D, dela Rosa C, Schiffman K

Journal:

Blood

Volume:

99(8)

Page:

2845-50

Review Article

Update on Breast Cancer Vaccines

2002

Authors:

Schiffman K and Disis ML

Journal:

Diseases of the Breast

Volume:

5(2)

Page:

1-14

bottom of page